Robert W. Hesslein's most recent trade in Voyager Therapeutics Inc was a trade of 4,410 Common Stock done at an average price of $7.8 . Disclosure was reported to the exchange on March 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 7.76 per share. | 20 Mar 2023 | 4,410 | 102,200 (0%) | 0% | 7.8 | 34,222 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 7.45 per share. | 17 Feb 2023 | 3,297 | 106,610 (0%) | 0% | 7.5 | 24,563 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 13 Feb 2023 | 2,868 | 109,907 (0%) | 0% | 7.7 | 21,998 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 9.57 per share. | 17 Jan 2023 | 1,396 | 113,567 (0%) | 0% | 9.6 | 13,360 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 17 Jan 2023 | 792 | 112,775 (0%) | 0% | 10.3 | 8,189 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 04 Apr 2022 | 2,786 | 114,963 (0%) | 0% | 8.3 | 22,985 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 8.29 per share. | 21 Mar 2022 | 4,897 | 117,807 (0%) | 0% | 8.3 | 40,596 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 8.67 per share. | 21 Mar 2022 | 58 | 117,749 (0%) | 0% | 8.7 | 503 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 3.55 per share. | 17 Feb 2022 | 4,100 | 122,704 (0%) | 0% | 3.6 | 14,555 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 3.36 per share. | 11 Feb 2022 | 3,252 | 126,804 (0%) | 0% | 3.4 | 10,927 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 20,000 | 130,056 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 4.95 per share. | 05 Apr 2021 | 3,292 | 110,056 (0%) | 0% | 4.9 | 16,295 | Common Stock |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 30,000 | 113,348 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 68,000 | 68,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 34,000 | 83,348 (0%) | 0% | 0 | Common Stock | |
| Voyager Therapeutics Inc | Robert W. Hesslein | Senior VP & General Counsel | Sale of securities on an exchange or to another person at price $ 7.55 per share. | 11 Feb 2021 | 3,186 | 49,348 (0%) | 0% | 7.5 | 24,054 | Common Stock |